|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Acute Lymphocytic Leukemia | |||||
| Acute Myeloid Leukemia | |||||
| Myelodysplastic Syndrome | |||||
| Non-Hodgkin Lymphoma | |||||
| Chronic Myelogenous Leukemia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Leukemia | |||||
| Leukemia, Lymphoid | |||||
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | |||||
| Leukemia, Myeloid | |||||
| Leukemia, Myeloid, Acute | |||||
| Lymphoma | |||||
| Lymphoma, Non-Hodgkin | |||||
| Myelodysplastic Syndromes | |||||
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | |||||
| Preleukemia | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Bone Marrow Diseases | |||||
| Disease | |||||
| Hematologic Diseases | |||||
| Immune System Diseases | |||||
| Immunoproliferative Disorders | |||||
| Lymphatic Diseases | |||||
| Lymphoproliferative Disorders | |||||
| Myeloproliferative Disorders | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Pathologic Processes | |||||
| Precancerous Conditions | |||||
| 4 | Sponsors listed in this trial | ||||
| ViaCell | |||||